169 related articles for article (PubMed ID: 24379912)
1. Betatrophin: A liver-derived hormone for the pancreatic β-cell proliferation.
Raghow R
World J Diabetes; 2013 Dec; 4(6):234-7. PubMed ID: 24379912
[TBL] [Abstract][Full Text] [Related]
2. Role of growth factors in control of pancreatic beta cell mass: focus on betatrophin.
Levitsky LL; Ardestani G; Rhoads DB
Curr Opin Pediatr; 2014 Aug; 26(4):475-9. PubMed ID: 24905104
[TBL] [Abstract][Full Text] [Related]
3. Betatrophin: a hormone that controls pancreatic β cell proliferation.
Yi P; Park JS; Melton DA
Cell; 2013 May; 153(4):747-58. PubMed ID: 23623304
[TBL] [Abstract][Full Text] [Related]
4. Circulating Betatrophin Levels Are Associated with the Lipid Profile in Type 2 Diabetes.
Ghasemi H; Tavilani H; Khodadadi I; Saidijam M; Karimi J
Chonnam Med J; 2015 Dec; 51(3):115-9. PubMed ID: 26730362
[TBL] [Abstract][Full Text] [Related]
5. Recombinant betatrophin (Angptl‑8/lipasin) ameliorates streptozotocin‑induced hyperglycemia and β‑cell destruction in neonatal rats.
Zhang D; Yu YJ; Xu FS; Yuan JH; Wang R; Zhang CS; Wang LX; Liu Y; Song LM; Liu JL; Dong J
Mol Med Rep; 2019 Nov; 20(5):4523-4532. PubMed ID: 31702044
[TBL] [Abstract][Full Text] [Related]
6. Associations of betatrophin levels with irisin in Chinese women with normal glucose tolerance.
Xie X; Gao T; Yang M; Chen P; Jin H; Yang L; Yu X
Diabetol Metab Syndr; 2015; 7():26. PubMed ID: 25859278
[TBL] [Abstract][Full Text] [Related]
7. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals.
Fenzl A; Itariu BK; Kosi L; Fritzer-Szekeres M; Kautzky-Willer A; Stulnig TM; Kiefer FW
Diabetologia; 2014 Jun; 57(6):1204-8. PubMed ID: 24623100
[TBL] [Abstract][Full Text] [Related]
8. Betatrophin expression is promoted in obese hyperinsulinemic type 2 but not type 1 diabetic mice.
Li E; Nakata M; Shinozaki A; Yang Y; Zhang B; Yada T
Endocr J; 2016 Jul; 63(7):611-9. PubMed ID: 27097546
[TBL] [Abstract][Full Text] [Related]
9. Betatrophin provides a new insight into diabetes treatment and lipid metabolism (Review).
Zhu JZ; Yu CH; Li YM
Biomed Rep; 2014 Jul; 2(4):447-451. PubMed ID: 24944788
[TBL] [Abstract][Full Text] [Related]
10. Betatrophin.
Ahnfelt-Rønne J; Madsen OD
Islets; 2014; 6(2):e28686. PubMed ID: 25483956
[TBL] [Abstract][Full Text] [Related]
11. Circulating betatrophin in healthy control and type 2 diabetic subjects and its association with metabolic parameters.
Al-Daghri NM; Rahman S; Sabico S; Amer OE; Wani K; Ansari MG; Al-Attas OS; Kumar S; Alokail MS
J Diabetes Complications; 2016; 30(7):1321-5. PubMed ID: 27311786
[TBL] [Abstract][Full Text] [Related]
12. Betatrophin and Insulin Resistance.
Guo Q; Cao S; Wang X
Metabolites; 2022 Sep; 12(10):. PubMed ID: 36295827
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of betatrophin in pancreatic cancer-associated diabetes.
Susanto H; Liu TY; Chen CC; Purnomo JD; Chen SF; Wang CH
Oncotarget; 2016 Jul; 7(27):42330-42339. PubMed ID: 27276680
[TBL] [Abstract][Full Text] [Related]
14. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance.
Chen X; Lu P; He W; Zhang J; Liu L; Yang Y; Liu Z; Xie J; Shao S; Du T; Su X; Zhou X; Hu S; Yuan G; Zhang M; Zhang H; Liu L; Wang D; Yu X
J Clin Endocrinol Metab; 2015 Jan; 100(1):E96-100. PubMed ID: 25303484
[TBL] [Abstract][Full Text] [Related]
15. Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients.
Wang L; Song J; Wang C; Lin P; Liang K; Sun Y; He T; Li W; Zhao R; Qin J; Lu Y; Liu J; Liu F; Hou X; Chen L
J Diabetes Res; 2016; 2016():2616539. PubMed ID: 26649318
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice.
Sun LL; Liu TJ; Li L; Tang W; Zou JJ; Chen XF; Zheng JY; Jiang BG; Shi YQ
Int J Mol Med; 2017 Apr; 39(4):936-948. PubMed ID: 28290605
[TBL] [Abstract][Full Text] [Related]
17. The correlation between plasma levels of oxytocin and betatrophin in non-diabetic and diabetic metabolic syndrome patients: A cross sectional study from Jordan.
Al-Rawashdeh A; Kasabri V; Bulatova N; Akour A; Zayed A; Momani M; Khawaja N; Bustanji H; Hyasat D
Diabetes Metab Syndr; 2017; 11(1):59-67. PubMed ID: 27578619
[TBL] [Abstract][Full Text] [Related]
18. Emerging regulation and function of betatrophin.
Tseng YH; Yeh YH; Chen WJ; Lin KH
Int J Mol Sci; 2014 Dec; 15(12):23640-57. PubMed ID: 25530616
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome.
Fu J; Hou C; Li L; Feng D; Li G; Li M; Li C; Gao S; Li M
Cardiovasc Diabetol; 2016 Oct; 15(1):142. PubMed ID: 27716289
[TBL] [Abstract][Full Text] [Related]
20. Circulating betatrophin in relation to metabolic, inflammatory parameters, and oxidative stress in patients with type 2 diabetes mellitus.
Hassan AB; Salih SF; Hassan II; Saadi FS; Abdulah DM; Ahmed IH; Taher SM; Khaleel BB
Diabetes Metab Syndr; 2019; 13(1):458-463. PubMed ID: 30641744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
